Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Lung UltrasoundRespiratory Distress Syndrome, Newborn
Interventions
DRUG

Intratracheal administration of surfactant

Intratracheal administration of pulmonary surfactant with any of the approved methods: (a) via endotracheal tube in a mechanically-ventilated infant, (b) with the INSURE method (intubation-surfactant-extubation), or (c) with LISA method (through a thin catheter inserted intratracheally in a spontaneously breathing infant, supported with CPAP)

Trial Locations (2)

31137

Department of Neonatology, Czerwiakowski Hospital at Siemiradzki st., Cracow, Poland, Krakow

Unknown

Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, Warsaw

All Listed Sponsors
collaborator

Polish Ultrasound Society, Neonatal Section

UNKNOWN

lead

Chiesi Poland Sp. z o.o.

INDUSTRY